dopetalk does not endorse any advertised product nor does it accept any liability for it's use or misuse

This website has run out of funding so feel free to contribute if you can afford it (see footer)

Author Topic: Price of cancer drugs vastly higher in US, according to study  (Read 6127 times)

Offline Chip (OP)

  • Server Admin
  • Hero Member
  • *****
  • Administrator
  • *****
  • Join Date: Dec 2014
  • Location: Australia
  • Posts: 6663
  • Reputation Power: 0
  • Chip has hidden their reputation power
  • Gender: Male
  • Last Login:Today at 07:38:54 AM
  • Deeply Confused Learner
  • Profession: IT Engineer
source: http://www.ft.com/cms/s/0/851cd240-2b6f-11e6-bf8d-26294ad519fc.html#axzz4AoBHJM88

Price of cancer drugs vastly higher in US, according to study

Median cost of branded monthly treatment is more than three times higher than in the UK



The price of cancer drugs in the US is vastly higher than in other nations, according to new research that shines a light on how the cost of treating the life-threatening disease differs considerably depending on where the patient lives.

In the US, the median monthly price of branded cancer drugs, which are still protected by patents, was almost $8,700, compared with about $2,600 in the UK, $2,700 in Australia and $3,200 in China, according to the study, one of the largest of its kind.
 
Researchers looked at the list prices of 23 drugs, eight of which were protected by patents, including four made by Roche, such as the blockbuster medicines Herceptin and Avastin, as well as treatments marketed by Eli Lilly, Takeda, Novartis and Bristol-Myers Squibb.

The study found wide differences in the retail price of drugs across six countries. The median monthly price of branded cancer medicines in India was $1,500, while in South Africa it was $1,700.

Generic copies of drugs that have lost patent protection were also more expensive in the US, according to the study, which looked at the list or “sticker” price for medicines and so did not factor in the discounts that big pharmaceutical companies tend to offer.

The research was released on Monday at the American Society of Clinical Oncologists in Chicago, the world’s largest gathering of cancer experts.

Traditionally, the conference has focused on science rather than cost but in the past two years, doctors have discussed pricing amid fears that “financial toxicity” could be hampering the battle against cancer.
 
Drug prices in the US have also become one of the main issues in the campaign for the White House, after a string of egregious price hikes by companies such as Turing Pharmaceuticals and Valeant sparked public outcry. Donald Trump and Hillary Clinton have each pledged to crack down on costs if elected president in November, prompting a sharp sell-off of pharmaceuticals stocks.



THIS CONTINUES ... read more here
friendly
0
funny
0
informative
0
agree
0
disagree
0
like
0
dislike
0
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
Our Discord Server invitation link is https://discord.gg/jB2qmRrxyD

Tags:
 

Related Topics

  Subject / Started by Replies Last post
1 Replies
15990 Views
Last post July 11, 2015, 11:51:32 AM
by Narkotikon
2 Replies
16329 Views
Last post July 29, 2015, 01:10:34 PM
by Narkotikon
8 Replies
11770 Views
Last post September 02, 2015, 10:56:04 PM
by hanna
1 Replies
8873 Views
Last post October 20, 2015, 12:31:41 PM
by Riddick
19 Replies
18792 Views
Last post February 02, 2016, 07:04:27 PM
by Griffin
1 Replies
8393 Views
Last post July 05, 2016, 10:30:39 PM
by Chip
0 Replies
9103 Views
Last post August 16, 2016, 12:35:42 PM
by Chip
0 Replies
7845 Views
Last post October 10, 2016, 07:42:02 PM
by Chip
0 Replies
7394 Views
Last post June 29, 2018, 01:49:56 PM
by Chip
2 Replies
8585 Views
Last post April 12, 2019, 08:44:54 PM
by Joseph Hopeless


dopetalk does not endorse any advertised product nor does it accept any liability for it's use or misuse





TERMS AND CONDITIONS

In no event will d&u or any person involved in creating, producing, or distributing site information be liable for any direct, indirect, incidental, punitive, special or consequential damages arising out of the use of or inability to use d&u. You agree to indemnify and hold harmless d&u, its domain founders, sponsors, maintainers, server administrators, volunteers and contributors from and against all liability, claims, damages, costs and expenses, including legal fees, that arise directly or indirectly from the use of any part of the d&u site.


TO USE THIS WEBSITE YOU MUST AGREE TO THE TERMS AND CONDITIONS ABOVE


Founded December 2014
SimplePortal 2.3.6 © 2008-2014, SimplePortal